ANI Pharmaceuticals
ANIP
ANIP
101 hedge funds and large institutions have $317M invested in ANI Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
40% more funds holding
Funds holding: 72 → 101 (+29)
36% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 22
Holders
101
Holding in Top 10
2
Calls
$672K
Puts
$118K
Top Buyers
| 1 | +$30.5M | |
| 2 | +$19.1M | |
| 3 | +$17.6M | |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$12.6M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$10.9M |
Top Sellers
| 1 | -$17.2M | |
| 2 | -$9.9M | |
| 3 | -$6.84M | |
| 4 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$5.14M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$4.75M |